Sweden Medical Diagnostics & Research Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Instant Alerts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
Medical Diagnostics & Research
Immunovia AB (LTS:0G8X) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Prudence Amidst Market Challenges
Immunovia AB (LTS:0G8X) showcases promising test results and financial strategies while navigating market hurdles and future growth plans. Dec 03, 2024
Medical Diagnostics & Research
Vimian Group AB (VIMGF) Q3 2024 Earnings Call Highlights: Strong Growth in Specialty Pharma and Veterinary Services
Despite challenges in diagnostics and the US market, Vimian Group AB (VIMGF) reports robust revenue and EBITDA growth, driven by strategic acquisitions and operational improvements. Oct 25, 2024
Medical Diagnostics & Research
Vimian Group AB (FRA:0V0) (Q2 2024) Earnings Call Transcript Highlights: Strong Organic Growth and Improved EBITDA Amid Market Challenges
Vimian Group AB (FRA:0V0) reports robust performance in key segments despite facing headwinds in diagnostics and the US surgical market. Aug 16, 2024
Medical Diagnostics & Research
Devyser Diagnostics AB (OSTO:DVYSR) Q2 2024 Earnings Call Transcript Highlights: Record Revenue and Strong Regional Growth Amid Rising Costs
Devyser Diagnostics AB (OSTO:DVYSR) reports a record SEK53.2 million in revenue and significant regional sales growth, despite increased costs and a negative EBIT. Jul 24, 2024